透過您的圖書館登入
IP:18.224.246.203
  • 期刊
  • OpenAccess

Acute Liver Injury after Initiating Atomoxetine in a Girl Patient with ADHD, Autism, and Epilepsy: The First Case Report in Taiwan

發生於一患有注意力不足過動症、自閉症與癲癇兒童病人之Atomoxetine相關肝臟損傷之個案報告

參考文獻


Stojanovski SD, Casavant MJ, Mousa HM, Baker P, Nahata MC: Atomoxetine-induced hepatitis in a child. Clin Toxicol (Phila). 2007; 45: 51-5.
Bangs ME, Jin L, Zhang SY, et al.: Hepatic events associated with atomoxetine treatment for attentiondeficit hyperactivity disorder. Drug Safety 2008; 31: 345-54.
SS Gau, YS Huang, WT Soong, et al.: A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007; 17: 447-60.
Lim JR, Faught PR, Chalasani NP, Molleston JP: Severe liver injury after initiating therapy with atomoxetine in two children. J Pediatr 2006; 148: 831-4.
Ruggiero S, Rafaniello C, Bravaccio C, et al.: Safety of attention-deficit/hyperactivity disorder medications in children: An intensive pharmacosurveillance monitoring study. J Child Adolesc Psychopharmacol 2012; 22: 415-22.

延伸閱讀